Strains of the Burkholderia cepacia complex have emerged as a serious threat to patients with cystic fibrosis due to their ability to infect the lung and cause, in some patients, a necrotizing pneumonia that is often lethal. It has recently been shown that several strains of the B. cepacia complex can escape intracellular killing by free-living amoebae following phagocytosis. In this work, the ability of two B. cepacia complex strains to resist killing by macrophages was explored. Using fluorescence microscopy, electron microscopy and a modified version of the gentamicin-protection assay, we demonstrate that B. cepacia CEP021 (genomovar VI), and Burkholderia vietnamiensis (previously B. cepacia genomovar V) CEP040 can survive in PU5- 1.8 murine macrophages for a period of at least 5 d without significant bacterial replication. Furthermore, bacterial entry into macrophages stimulated production of tumour necrosis factor and primed them to release toxic oxygen radicals following treatment with phorbol myristoyl acetate. These effects were probably caused by bacterial LPS, as they were blocked by polymyxin B. Infected macrophages primed with interferon gamma produced less nitric oxide than interferon-gamma- primed uninfected cells. We propose that the ability of B. cepacia to resist intracellular killing by phagocytic cells may play a role in the pathogenesis of cystic fibrosis lung infection. Our data are consistent with a model where repeated cycles of phagocytosis and cellular activation without bacterial killing may promote a deleterious inflammatory response causing tissue destruction and decay of lung function.
AmanoF., NodaT.1995; Improved detection of nitric oxide radical (NO·) production in an activated macrophage culture with a radical scavenger, carboxy PTIO, and Griess reagent. FEBS Lett 368:425–428[CrossRef]
BassD. A., ParceJ. W., DechateletL. R. P. S., SeedsM. C., ThomasM.1983; Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130:1910–1917
BiragynA., NedospasovS. A.1995; Lipopolysaccharide-induced expression of TNF-α gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. J Immunol 155:674–683
ChengP. W., BoatT. F., CranfillK., YankaskasJ. R., BoucherR. C.1989; Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest 84:68–72[CrossRef]
CrowleA. J., SbarbaroJ. A., JudsonF. N., DouvasG. S., MayM. H.1984; Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. Am Rev Respir Dis 130:839–844
DofferhoffA. S., EsselinkM. T., de Vries-HospersH. G., van ZantenA., BomV. J., WeitsJ., VellengaE.1993; The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother 31:373–384[CrossRef]
GessnerA. R., MortensenJ. E.1990; Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol 33:115–120[CrossRef]
GrangerD. L., HibbsJ. B., PerfectJ. R., DurackD. T.1990; Metabolic fate of l- arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest 85:264–267[CrossRef]
GuthrieL. A., McPhailL. C., HensonP. M., JohnstonR. B.1984; Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide: evidence for increased activity of the superoxide- producing enzyme. J Exp Med 160:1656–1671[CrossRef]
HassettD. J., CohenM. S.1989; Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J 3:2574–2582
HughesJ. E., StewartJ., BarclayG. R., GovanJ. R.1997; Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia . Infect Immun 65:4281–4287
HutchinsonM. L., PoxtonI. R., GovanJ. R.1998; Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun 66:2033–2039
LasfarguesA., Tahri-JoutiM. A., PedronT., GirardR., ChabyR.1989; Effects of lipopolysaccharide on macrophages analyzed with anti-lipid A monoclonal antibodies and polymyxin B. Eur J Immunol 19:2219–2225[CrossRef]
van de LoosdrechtA. A., NennieE., OssenkoppeleG. J., BeelenR. H., LangenhuijsenM. M.1991; Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay: a methodological study. . J Immunol Methods 141:15–22[CrossRef]
MaroldaC. L., HauröderB., JohnM. A., MichelR., ValvanoM. A.1999; Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae. Microbiology 145:1509–1517[CrossRef]
MartinC. A., DorfM. E.1990; Interleukin-6 production by murine macrophage cell lines P388D1 and J774A.1: stimulation requirements and kinetics. Cell Immunol 128:555–568[CrossRef]
MehtaP. K., KingC. H., WhiteE. H., MutaghJ. J., QuinnF. D.1996; Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect Immun 64:2673–2679
OelschlaegerT. A., TallB. D.1997; Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infect Immun 65:2950–2958
PerottoS., BonfanteP.1997; Bacterial associations with mycorrhizal fungi: close and distant friends in the rhizosphere. Trends Microbiol 5:496–501[CrossRef]
SalzmanG. C., SinghamS. B., JohnstonR. G., BohrenC. F.1990; Light scattering and cytometry. In Flow Cytometry and Sorting pp. 81–107Edited by MelamedM. R., LindmoT., MendelsohnM. L. New York: Wiley-Liss;
SmithA. W., GreenJ., EdenC. E., WatsonM. L.1999; Nitric oxide-induced potentiation of the killing of Burkholderia cepacia by reactive oxygen species: implications for cystic fibrosis. . J Med Microbiol 48:419–423[CrossRef]
SpeertD. P., BondM., WoodmanR. C., CurnutteJ. T.1994; Infection with Pseudomonas cepacia in chronic granulomatosis disease: role of non-oxidative killing by neutrophils in host defense. J Infect Dis 170:1524–1531[CrossRef]
StuehrD. J., MarlettaM.1985; Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82:7738–7742[CrossRef]
StuehrD. J., MarlettaM.1987; Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J Immunol 139:518–525
SummersgillJ. T., PowellL. A., BusterB. L., MillerR. D., RamirezJ. A.1992; Killing of Legionella pneumophila by nitric oxide in gamma-interferon- activated macrophages. J Leukoc Biol 52:625–629
VandammeP., HolmesB., VancanneytM.8 other authors1997; Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 47:1188–1200[CrossRef]
VosbeckK., TobiasP., MuellerH., AllenR. A., ArforsK. E., UlevitchR. J., SklarL. A.1990; Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. . J Leukoc Biol 47:97–104
WewersM. D.1997; Cytokines and macrophages. In Cytokines in Health and Disease pp. 339–355Edited byRemickD. G. , FriedlandJ. S. New York: Marcel Dekker;
YaoZ., LiuH., ValvanoM. A.1992; Acetylation of O- specific lipopolysaccharides from Shigella flexneri 3a and 2a occurs in Escherichia coli K-12 carrying cloned S. flexneri 3a and 2a rfb genes. J Bacteriol 174:7500–7508
ZughaierS. M., RyleyH. C., JacksonS. K.1999; Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumour necrosis factor alpha from human monocytes. . Infect Immun 67:1505–1507